Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed Dose vs Concentration Controlled MMF in Renal Transplant
NCT00166244Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- May 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 19
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in renal transplant rejection (RTR) (2 arms), sponsored by Erasmus MC. Primary endpoint: Treatment failure at 12 months. Started May 2003; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT00166244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166244.